ScholarWorks@Korea University: Park, Man Seong

Detailed Information

Park, Man Seong (박만성)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 02-2286-1312
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

SARSCoV2:23||COVID19:21||influenza virus:5||ELISA:4||Influenza:4||influenza A virus:4||variants:3||vaccine:3||Transmission:3||MERSCoV:3||Vaccine:3||neutralization assay:2||viral shedding:2||phylogeny:2||Neuraminidase:2||Viral shedding:2||subgenomic RNA:2||neutralizing antibodies:2||Antiviral:2||neutralizing antibody:2||spike protein:2||B cell epitope:2||Isolation policy:2||K18hACE2 mouse:2||Lactobacillus plantarum:2||Middle East respiratory syndrome coronavirus:2||Virus:2||Hantaan virus:2||Monoclonal antibody:2||Hemagglutinin:2||Compartmental microneedle array:1||B/Victoria:1||Pathogenicity:1||Virus isolation:1||centrifugation:1||human metapneumovirus:1||membrane fusion:1||Spike protein:1||Vaccine effectiveness:1||Dengue virus:1||Serotyping:1||salinomycin:1||pathogenicity:1||polymerase:1||influenza:1||kimchi:1||Human betadefensin:1||glycoprotein:1||EIF2AK2:1||Virus culture:1||Close Contact:1||BNT162b2:1||Predictive model:1||isolation:1||humoral immunity:1||spike Cterminal domain:1||Infection dynamics:1||genotype:1||evolution:1||reassortment:1||SARSCoV2 Omicron:1||B/Yamagata:1||Epidemiologic survey:1||innate immunity:1||NS1 evolution:1||Lowtemperature process:1||apoptosis:1||M2 ion channel:1||Prophylactic:1||Adenovirus:1||Original antigenic sin:1||IL12:1||Influenza A virus:1||Aggrephagy:1||CTIF:1||immune response:1||Airborne Transmission:1||rapid antigen test:1||monoclonal antibody:1||K18hACE2 mice:1||viral replication:1||Antibodies:1||targeting:1||cytokines:1||barcoded library:1||H1N1:1||Lipoplex (O):1||Molecular evolution:1||TaqMan probe:1||Realtime PCR:1||Therapeutic:1||heatkilled probiotic:1||Red squirrel:1||Interferon:1||orthohantavirus:1||Subgenomic RNA:1||viruscell fusion:1||cell culture:1||cellpermeable peptide:1||chemiluminescence immunoassay:1||Xenograft mouse model:1||Bivalent influenza vaccine:1||Phylogenetic analysis:1||Microneedles:1||receptor binding domain:1||adaptation:1||influenza B virus:1||Penton base:1||Phylogeny:1||Influenza A(H7N9) virus:1||Burn wounds:1||Newcastle disease virus:1||Cell entry:1||COV2:1||Hematologic Malignancy:1||deisolation:1||Longterm infection model:1||Mutants:1||respiratory syncytial virus:1||Jeju orthohantavirus:1||Crocidura shantungensis:1||antiviral agents:1||cross protection:1||molecular evolution:1||zoonoses:1||antiviral agent:1||Hexon:1||Pseudomonas aeruginosa:1||Drug repurposing:1||CRISPRCas12a:1||Contact Tracing:1||mRNA1273:1||severe acute respiratory syndrome coronavirus 2:1||Vaccination:1||N protein:1||infection dynamics:1||Syrian golden hamster:1||severe fever with thrombocytopenia syndrome virus:1||longterm replication model:1||infection:1||organ failure:1||Animal model:1||AZD1480:1||Temperaturesensitive:1||small molecule:1||Dietary supplement:1||Adjuvant:1||Cordyceps extract:1||NS1 protein:1||PDZbinding motif:1||diagnosis:1||DETECTR:1||Safety:1||ChAdOx1 nCoV19:1||aerosol transmission:1||coronavirus:1||outbreak investigation:1||ANO6/TMEM16F:1||CP: Microbiology:1||phosphatidylserine:1||cellular immunity:1||immunemediated response:1||transcriptome profiling:1||culture:1||Nonclinical:1||hACE2 mouse:1||Golden Syrian hamster:1||Virus shedding:1||reverse genetics:1||neutralizing:1||abdominal organs:1||Korean peninsula:1||Pandemic:1||human respiratory syncytial virus:1||M protein:1||hemagglutinin stalk:1||peritoneal cells:1||combination treatment:1||ionophore:1||Leuconostoc mesenteroides:1||probiotic:1||Defensin:1||NK cells:1||immunity:1||antigenicity:1||SARS CoV2:1||viable culture:1||Immunogenicity:1||WholeGenome Sequencing:1||PostIsolation Transmission:1||vaccines:1||booster:1||Delta variant:1||Infection dynamic:1||RNAdependent RNA polymerase:1||Seoul virus:1||RSV:1||nucleocapsid protein:1||Single administration:1||chemokines:1||Zoonosis:1||IFN response:1||orthomyxovirus:1||Stabilizer:1||Nlinked glycosylation:1||Dengue:1||Cellular proteins:1||Antiviral drugs:1||pandemic:1||DCTN1:1||Infective viral shedding:1||RDT:1||presymptomatic:1||Hantavirus:1||Ad26:1||S:1||breakthrough infection:1||virus shedding:1||virulence:1||immunogenicity:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE